文献速递慢性静脉疾病

下肢静脉性溃疡疾病外科与腔内介入治疗的系统评价网络荟萃分析及荟萃回归

A Systematic Review Network Meta-Analysis and Meta-Regression on Surgical and Endovenous Interventions for the Treatment of Lower Limb Venous Ulcer Disease.
PubMed 文献 · J Endovasc Ther · 2023-08-17

该系统评价网络荟萃分析纳入17项研究共2156例患者(2186处静脉性溃疡),比较单纯压力治疗、射频消融、腔内激光消融、硬化治疗和隐静脉手术对溃疡愈合与复发的影响。与单纯压力治疗相比,仅射频消融对溃疡愈合有统计学显著影响(OR 5.80,95%CI 1.08-35.07);腔内激光消融、硬化治疗和射频消融均降低溃疡复发。腔内激光消融为复发减少排名最高的干预(SUCRA 69.65),但并发症风险较单纯压力治疗显著增加(RR 14.3,95%CI 2.03-172.56)。

要点

  • 与单纯压力治疗相比,仅射频消融对静脉性溃疡愈合有统计学显著影响(OR 5.80,95%CI 1.08-35.07)。
  • 腔内激光消融(RR 0.06)、硬化治疗(RR 0.07)和射频消融(RR 0.12)均降低溃疡复发。
  • 腔内激光消融并发症风险较单纯压力治疗显著增加(RR 14.3,95%CI 2.03-172.56)。

核心结论

  • 这是首个探讨多种干预对静脉性溃疡疾病效果的网络荟萃分析;作者展示了射频消融和腔内激光消融在预防溃疡复发方面的疗效,但射频消融对溃疡愈合及硬化治疗对溃疡复发的结果应谨慎解读。
  • 本综述对手术和穿通支干预在静脉性溃疡治疗中的价值提出了疑问;作者认为需要进一步的随机对照试验研究。

研究设计与样本

  • 按照PRISMA声明的指示进行系统检索,纳入报告外科或腔内介入治疗静脉性溃疡的研究。
  • 共纳入17项研究,评估单纯压力治疗、射频消融、腔内激光消融、硬化治疗和隐静脉手术对静脉性溃疡治疗的影响,合计2156例患者(2186处静脉性溃疡)。
  • 进行贝叶斯网络荟萃分析和荟萃回归;主要终点为静脉性溃疡愈合和复发,次要终点为干预后并发症。

主要发现

  • 与单纯压力治疗相比,射频消融是唯一对溃疡愈合显示统计学显著影响的治疗,OR 5.80(95%CI 1.08-35.07)。
  • 与单纯压力治疗相比,腔内激光消融(RR 0.06,95%CI 0.00-0.57)、硬化治疗(RR 0.07,95%CI 0.00-0.68)和射频消融(RR 0.12,95%CI 0.01-0.91)是降低静脉性溃疡复发的3种干预。
  • 关于溃疡复发减少,腔内激光消融排名为最有效的干预(SUCRA 69.65)。
  • 关于干预后并发症,腔内激光消融是唯一较单纯压力治疗显示统计学显著风险增加的干预,RR 14.3(95%CI 2.03-172.56)。
  • 荟萃回归分析探讨穿通支治疗对静脉性溃疡的影响,未能预测愈合(β=-0.27,95%CI -2.55至1.85)、复发(β=-0.02,95%CI -2.96至2.75)和并发症结局(β=-0.089,95%CI -3.13至2.85)。

关键数值与推荐

  • 与单纯压力治疗相比,射频消融对溃疡愈合的OR 5.80(95%CI 1.08-35.07)。
  • 与单纯压力治疗相比,腔内激光消融降低溃疡复发的RR 0.06(95%CI 0.00-0.57)。
  • 与单纯压力治疗相比,硬化治疗降低溃疡复发的RR 0.07(95%CI 0.00-0.68)。
  • 与单纯压力治疗相比,射频消融降低溃疡复发的RR 0.12(95%CI 0.01-0.91)。
  • 与单纯压力治疗相比,腔内激光消融增加干预后并发症风险的RR 14.3(95%CI 2.03-172.56)。

临床怎么用

  • 作者认为,腔内激光消融和射频消融在有效减少溃疡复发方面具有显著疗效,这些结果可能为医疗从业者和患者提供相关见解,从而有助于制定更审慎和明智的决策。
  • 作者指出,射频消融对溃疡愈合及硬化治疗对溃疡复发的结果应谨慎解读。
  • 作者认为,本综述对手术和穿通支干预在静脉性溃疡治疗中的价值提出了疑问,需要进一步的随机对照试验研究。

局限性

  • 在敏感性分析中,射频消融和硬化治疗分别未能维持其对溃疡愈合和溃疡复发的作用。
  • 硬化治疗在溃疡复发方面较腔内激光消融和射频消融均显示统计学显著较差的结果。
  • 作者认为需要进一步的随机对照试验研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous leg ulcer (VLU) disease constitutes the most severe form of chronic venous insufficiency. We performed a network meta-analysis and meta-regression to investigate the efficacy and safety of the various available interventions in the treatment of VLU. METHODS: We conducted a systematic research corresponding to the instructions by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement for studies reporting on surgical or endovenous interventions for the treatment of VLU. Following data extraction, we performed a Bayesian network meta-analysis and meta-regression. Primary endpoints included VLU healing and recurrence. The secondary endpoint was postintervention complications. RESULTS: Seventeen studies evaluating the impact of compression monotherapy, radiofrequency ablation (RFA), endovenous laser ablation (EVLA), sclerotherapy, and saphenous vein surgery on VLU treatment, consisting of 2156 patients (2186 VLU) were included. When compared to compression monotherapy, RFA was the only treatment displaying a statistically-significant impact on ulcer healing, odds ratio (OR) 5.80 (95% credibility interval (CI): 1.08-35.07), while EVLA, RR 0.06 (95% CI: 0.00-0.57), sclerotherapy, RR 0.07 (95% CI: 0.00-0.68) and RFA, RR 0.12 (95% CI: 0.01-0.91) were the 3 interventions reducing VLU recurrence. EVLA (SUCRA, 69.65) ranked as the most efficient intervention concerning ulcer recurrence reduction. Regarding postintervention complications, EVLA was the only intervention displaying a statistically-significant increased risk compared to compression monotherapy, RR 14.3 (95% CI: 2.03-172.56). Meta-regression analysis exploring the impact of perforator treatment on VLU failed to predict healing, β = -0.27 (95% CI: -2.55 to 1.85), recurrence, β = -0.02 (95% CI: -2.96 to 2.75) and complication outcomes, β = -0.089 (95% CI: -3.13 to 2.85). During sensitivity analysis, RFA and sclerotherapy failed to sustain their effects on ulcer healing and ulcer recurrence, respectively. In addition, sclerotherapy displayed statistically-significant inferior outcomes compared to both EVLA and RFA regarding ulcer recurrence. CONCLUSION: This is the first network meta-analysis examining the effect of various interventions on VLU disease. While we have demonstrated the efficacy of RFA and ELVA in ulcer recurrence prevention, our results regarding the impact of RFA and sclerotherapy on VLU healing and recurrence, respectively, should be interpreted with caution. In addition, this review raises questions concerning the value of surgery and perforator interventions in the treatment of VLU. Further research through randomized controlled trials is required.Clinical impactOur review has revealed the significant efficacy of endovenous laser ablation (EVLA) and radiofrequency ablation (RFA) in effectively reducing the incidence of ulcer recurrence when compared to compression monotherapy. These outcomes hold the potential to provide relevant insights to both medical practitioners and patients, thereby informing a more prudent and enlightened decision-making approach. Such informed decisions, aimed at mitigating the recurring occurrence of venous leg ulcers, carry profound significance given the considerable socioeconomic implications associated with this medical condition.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Bontinis V, Ktenidis K, Bontinis A, et al. A Systematic Review Network Meta-Analysis and Meta-Regression on Surgical and Endovenous Interventions for the Treatment of Lower Limb Venous Ulcer Disease. J Endovasc Ther. 2023. PMID: 37592807. doi:10.1177/15266028231193978

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。